{"slideshow_credits": null, "snippet": "In a second bid for its British rival, American drug giant Pfizer on Friday increased its offer by 7 percent. But AstraZeneca said the terms substantially undervalued the company.", "abstract": "In a second bid for its British rival, American drug giant Pfizer on Friday increased its offer by 7 percent. But AstraZeneca said the terms substantially undervalued the company.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}, {"firstname": "Stephen", "role": "reported", "lastname": "CASTLE", "rank": 2, "organization": ""}], "original": "By CHAD BRAY and STEPHEN CASTLE"}, "web_url": "http://dealbook.nytimes.com/2014/05/02/pfizer-raises-bid-for-astrazeneca-putting-pressure-on-drug-maker-to-make-deal/", "lead_paragraph": null, "headline": {"main": "AstraZeneca Rejects a Higher Bid From Pfizer", "print_headline": "AstraZeneca Turns Down Higher Bid From Pfizer", "kicker": "DealBook"}, "_id": "53633d7638f0d84d9e271333", "word_count": "1036", "multimedia": [{"height": 126, "url": "images/2014/05/03/business/SubPfizer1/SubPfizer1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/03/business/SubPfizer1/SubPfizer1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/05/03/business/Pfizer2/Pfizer2-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/03/business/Pfizer2/Pfizer2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/03/business/SubPfizer1/SubPfizer1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/03/business/SubPfizer1/SubPfizer1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-02T02:37:11Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "glocations", "value": "Great Britain", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "rank": "2"}, {"name": "organizations", "value": "Warner-Lambert Co", "rank": "3"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": "1"}, {"name": "subject", "value": "Stocks and Bonds", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}